EP3936130
VALBENAZINE DOSAGE REGIMEN FOR THE TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS
:
EP einkaleyfi í gildi á Íslandi:
6.5.2015:
14.2.2024:
21178882.3
:
29.4.2024:
15.6.2024
:
5.5.2035:
5.5.2026:
31.5.2026
:
VALBENAZINE DOSAGE REGIMEN FOR THE TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS
6.5.2015
14.2.2024
29.4.2024
15.6.2024
5.5.2026
:
Neurocrine Biosciences, Inc.:
12780 El Camino Real, San Diego, California 92130, US
:
O'BRIEN, Christopher:
San Diego, 92130, US
:
201461989240 P:
6.5.2014:
US
:
A61K 31/473, A61P 25/00, A61P 25/14, A61P 43/00
: 10
: 18.4.2024
: 5.5.2025
: Árnason Faktor ehf.
: 11
: 6.5.2025
: 5.5.2026
: Árnason Faktor ehf.